Status:
UNKNOWN
Prediction of Lymph Node Invasion for Prostate Adenocarcinoma
Lead Sponsor:
University Hospital, Brest
Conditions:
Adenocarcinoma of the Prostate
Eligibility:
MALE
18+ years
Brief Summary
Despite lymph node involvement (LNI) being one of the main prognostic factors in patients with prostate cancer (PCa), pelvic lymph node irradiation remains debated, possibly due to an insufficient sel...
Eligibility Criteria
Inclusion
- Histologically proven adenocarcinoma of the prostate treated by prostatectomy with extensive lymph node dissection
- Available pre-operative +/- PET choline
Exclusion
- Unanalyzable pre-operative MRI
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 30 2022
Estimated Enrollment :
400 Patients enrolled
Trial Details
Trial ID
NCT04909957
Start Date
January 1 2021
End Date
November 30 2022
Last Update
January 19 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHRU Brest
Brest, France, 29200